Day: September 11, 2023

APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF)

Staff September 11, 2023

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

Staff September 11, 2023

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

Staff September 11, 2023

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics

Staff September 11, 2023

XORTX Announces Participation at Upcoming Investor Conferences

Staff September 11, 2023

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

Staff September 11, 2023

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

Staff September 11, 2023

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

Staff September 11, 2023

Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph.D. as Chief Commercial Officer as it Enters Pre-Commercial Phase

Staff September 11, 2023

Justera Health Launches Health and Wellness Retail Stores

Staff September 11, 2023

Toronto, Ontario--(Newsfile Corp. - September 11, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (formerly ScreenPro Security Inc.) ("Justera" or the...

Save the date: IRLAB holds Capital Markets Day on October 17, 2023

Staff September 11, 2023

GOTHENBURG, SE / ACCESSWIRE / September 11, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 11, 2023 - IRLAB...

Day: September 11, 2023

APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF)

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics

XORTX Announces Participation at Upcoming Investor Conferences

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph.D. as Chief Commercial Officer as it Enters Pre-Commercial Phase

Justera Health Launches Health and Wellness Retail Stores

Save the date: IRLAB holds Capital Markets Day on October 17, 2023

Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring

Fitness App Market to Expand by USD 55.86 Billion (2024-2028), Driven by Health Management and Rising Chronic Disease Cases, AI Impacting Market Trends – Technavio

Defence Announces Closing of Securities for Debenture Financing

NuGen Announces Canada-Wide Launch of InsuJet

purelyIV Launches Mobile App for Seamless Wellness Management

You may have missed